Fundamentals Overview
Ovintiv Inc. is near the high of its 52-week range with moderate valuation, trading relatively flat today.
Valuation moderate
Intrinsic value (DCF)
+49.8% upside vs price
Profitability
Risk (Beta)
0.6 — lower vol
Earnings & growth
BullzEye Analysis
Our composite tilts Buy on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.
Composite Signal
Supporting (Buy):
DCF +49.8% upside vs price · Analyst grade: A- · 3M vs S&P 500: +40.6% · 3M vs Energy sector: +20.9%
Pressures (Sell):
Sentiment weakening (2 downgrades)
Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.
Key Stats
About
Ratings & Grades at a Glance
Overall rating: A-. Recent institutional grades: majority downgrades. Current institutional positions: Buy: 12, Equal Weight: 5, Neutral: 2, Outperform: 5, Overweight: 5, Sector Outperform: 1.
Valuation & Ratios
Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.
DCF vs price: DCF estimate is $82.45; current price is $55.04. That’s a +49.8% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.
| Metric | Value |
|---|---|
| Valuation | |
| P/E (TTM) | 11.51 |
| DCF value (model) | $82.45 (49.8% upside) |
| PEG (TTM) | 1.11 |
| P/B (TTM) | 1.26 |
| P/S (TTM) | 1.77 |
| P/FCF (TTM) | 4.31 |
| Liquidity & enterprise | |
| Current Ratio (TTM) | 0.54 |
| Quick Ratio (TTM) | 0.54 |
| Cash Ratio (TTM) | 0.01 |
| Profitability | |
| ROE (TTM) | N/A |
| ROA (TTM) | N/A |
| Revenue growth (YoY) | N/A |
| Net margin (TTM) | 14.13% |
| Gross margin (TTM) | 47.09% |
| Operating margin (TTM) | 12.59% |
| Debt to equity (TTM) | N/A |
Latest News
News loads when you open this tab.
Price Target, Ratings & Grades
Analyst price targets, consensus, rating snapshot, and institutional grades for OVV.
Analyst Sentiment at a Glance
Stock Grades (Institutions)
| Institution | Action | Previous Grade | New Grade | Date |
|---|---|---|---|---|
| UBS | maintain | Buy | Buy | 2026-04-09 |
| B of A Securities | maintain | Buy | Buy | 2026-04-02 |
| Citigroup | downgrade | Buy | Neutral | 2026-03-30 |
| Truist Securities | maintain | Buy | Buy | 2026-03-24 |
| Wells Fargo | maintain | Equal Weight | Equal Weight | 2026-03-19 |
| Scotiabank | maintain | Sector Outperform | Sector Outperform | 2026-03-19 |
| Mizuho | maintain | Outperform | Outperform | 2026-03-17 |
| TD Cowen | maintain | Buy | Buy | 2026-03-17 |
| Barclays | maintain | Overweight | Overweight | 2026-03-16 |
| Goldman Sachs | maintain | Buy | Buy | 2026-03-11 |
| UBS | maintain | Buy | Buy | 2026-03-05 |
| UBS | maintain | Buy | Buy | 2026-02-25 |
| Evercore ISI Group | maintain | Outperform | Outperform | 2026-02-25 |
| Barclays | maintain | Overweight | Overweight | 2026-02-25 |
| Roth Capital | maintain | Neutral | Neutral | 2026-02-24 |
| UBS | maintain | Buy | Buy | 2026-02-18 |
| UBS | maintain | Buy | Buy | 2025-12-12 |
| UBS | maintain | Buy | Buy | 2025-11-21 |
| Wells Fargo | maintain | Equal Weight | Equal Weight | 2025-11-18 |
| Citigroup | maintain | Buy | Buy | 2025-11-18 |
| Wells Fargo | maintain | Equal Weight | Equal Weight | 2025-10-17 |
| RBC Capital | upgrade | Sector Perform | Outperform | 2025-10-15 |
| Morgan Stanley | maintain | Equal Weight | Equal Weight | 2025-10-14 |
| Barclays | maintain | Overweight | Overweight | 2025-10-07 |
| Evercore ISI Group | maintain | Outperform | Outperform | 2025-10-06 |
| JP Morgan | maintain | Overweight | Overweight | 2025-10-03 |
| Mizuho | maintain | Outperform | Outperform | 2025-09-15 |
| UBS | maintain | Buy | Buy | 2025-08-20 |
| Morgan Stanley | downgrade | Overweight | Equal Weight | 2025-08-18 |
| JP Morgan | maintain | Overweight | Overweight | 2025-07-28 |